--- title: "PMGC Holdings Inc. (ELAB.US)" type: "quote" locale: "en" url: "https://longbridge.com/en/quote/ELAB.US.md" symbol: "ELAB.US" name: "PMGC Holdings Inc." industry: "個人護理產品" --- # PMGC Holdings Inc. (ELAB.US) | Item | Detail | |------|--------| | Industry | 個人護理產品 | | Location | 美股市場 | | Website | [mgcholdings.com](https://mgcholdings.com) | ## Company Profile PMGC Holdings Inc.是一家生物制藥公司,專注于前沿美容藥物和治療產品的開發與收購。該公司的主打產品包括 EL-22,這是一種首創的工程化益生菌方法,旨在解決肥胖患者在減重治療(包括 GLP-1 受體激動劑)過程中保持肌肉的問題。公司還參與醫學科學研究與開發活動,並運營投資公司。該公司之前被稱為 Elevai Labs, Inc ## Financial Score > *Longbridge Financial Score™ — Proprietary multi-factor rating model by [Longbridge](https://longbridge.com). This score is independently calculated by Longbridge and is not affiliated with any third-party rating agency.* > Updated: 2026-03-01T04:30:12.000Z **Overall: C (0.57)** **Industry**: Personal Care Products | Metric | Value | |--------|-------| | Industry Ranking | 41 / 58 | | Industry Median | C | | Industry Average | C | - **Style**: Blend - Stocks in which the company has both growth and mature businesses. - **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns. ### Score Analysis **Style Score**: #### Growth Score: | Indicator | Value | Rating | |-----------|-------|--------| | Revenue YoY | 128.20% | | | Net Profit YoY | -22.51% | | #### Value Score: | Indicator | Value | Rating | |-----------|-------|--------| | P/B Ratio | 0.17 | | | Dividend Ratio | 0.00% | | **Size Score**: #### Market Cap Score: | Indicator | Value | Rating | |-----------|-------|--------| | Market Cap | 1.41M | | #### Revenue Score: | Indicator | Value | Rating | |-----------|-------|--------| | Revenue | 285948.00 | | **Multi Score**: C #### Profit Score: E | Indicator | Value | Rating | |-----------|-------|--------| | ROE | -76.20% | E | | Profit Margin | -2343.04% | E | | Gross Margin | -82.03% | E | #### Growth Score: B | Indicator | Value | Rating | |-----------|-------|--------| | Revenue YoY | 128.20% | A | | Net Profit YoY | -22.51% | D | | Total Assets YoY | 33.31% | A | | Net Assets YoY | -0.75% | D | #### Cash Score: B | Indicator | Value | Rating | |-----------|-------|--------| | Cash Flow Margin | -4.27% | D | | OCF YoY | 128.20% | A | #### Operating Score: E | Indicator | Value | Rating | |-----------|-------|--------| | Turnover | 0.02 | E | #### Debt Score: C | Indicator | Value | Rating | |-----------|-------|--------| | Gearing Ratio | 43.16% | C | ```chart-data:radar { "title": "Longbridge Financial Score - PMGC Holdings Inc.", "chart_type": "radar", "dimensions": [ { "name": "Profit", "grade": "E", "indicators": [ { "name": "ROE", "value": "-76.20%", "rating": "E" }, { "name": "Profit Margin", "value": "-2343.04%", "rating": "E" }, { "name": "Gross Margin", "value": "-82.03%", "rating": "E" } ] }, { "name": "Growth", "grade": "B", "indicators": [ { "name": "Revenue YoY", "value": "128.20%", "rating": "A" }, { "name": "Net Profit YoY", "value": "-22.51%", "rating": "D" }, { "name": "Total Assets YoY", "value": "33.31%", "rating": "A" }, { "name": "Net Assets YoY", "value": "-0.75%", "rating": "D" } ] }, { "name": "Cash", "grade": "B", "indicators": [ { "name": "Cash Flow Margin", "value": "-4.27%", "rating": "D" }, { "name": "OCF YoY", "value": "128.20%", "rating": "A" } ] }, { "name": "Operating", "grade": "E", "indicators": [ { "name": "Turnover", "value": "0.02", "rating": "E" } ] }, { "name": "Security", "grade": "C", "indicators": [ { "name": "Gearing Ratio", "value": "43.16%", "rating": "C" } ] } ] } ``` ### Peer Comparison | Rank | Name | Profit | Growth | Operation | Security | Cash | Rating | |------|------|--------|--------|-----------|----------|------|--------| | 01 | Niagen Bioscience (US.NAGE) | A | A | A | B | B | A | | 02 | 歐萊雅(ADR) (US.LRLCY) | A | B | B | C | B | B | | 03 | 拜耳斯道夫(ADR) (US.BDRFY) | B | C | B | B | B | B | | 04 | 花王(ADR) (US.KAOOY) | B | C | A | C | B | B | | 05 | ELF Beauty (US.ELF) | B | B | B | C | B | B | ## Valuation Analysis | Metric | Current | Industry Ranking | High | Median | Low | |--------|---------|-----------------|------|--------|-----| | PE (TTM) | -0.21 | 23/56 | - | - | - | | PB | 0.17 | 2/56 | 0.45 | 0.35 | 0.25 | | PS (TTM) | 4.93 | 42/56 | 6.64 | 1.74 | 1.74 | | Dividend Yield | 0.00% | - | - | - | - | ## References - [Company Overview](https://longbridge.com/en/quote/ELAB.US/overview.md) - Shareholders, executives, business segments - [Financials](https://longbridge.com/en/quote/ELAB.US/norm.md) - Income statement, balance sheet, cash flow, distribution plan - [Topics & Discussions](https://longbridge.com/en/quote/ELAB.US/topics.md) - Community topics and discussions --- > **Disclaimer**: This article is for reference only and does not constitute any investment advice.